MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0043145
Priority Pharmaceuticals Private Limited - pharma in Jaipur, Rajasthan, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹7.12 Cr
▲ 174% YoY
Net profit · FY 2025
₹15.66 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹61.8 Lakh
EBITDA margin 8.7%
Authorised capital
₹11 Lakh
Registered with MCA
Paid-up capital
₹11 Lakh
Issued & subscribed
Open charges
₹58.24 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
4
As per MCA filings
About Priority Pharmaceuticals Private Limited
Data last updated:
Priority Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2011PTC035282. Its GSTIN is 08AAGCP0181N1Z4 (Rajasthan).
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹11 Lakh. It is led by directors including Sonakshi Jain and Sanjay Kumar Patni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 194 2nd Floor Near Moti Park Bapu Nagar, Jaipur, Rajasthan, India – 302015.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.12 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹15.66 Lakh (net margin 2.2%) and EBITDA of ₹61.8 Lakh (EBITDA margin 8.7%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years and 28% over five years.
The company is associated with 1 brand: Priority Pharmaceuticals. As per MCA filings, the company has open charges of ₹58.24 Lakh on record.
Priority Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0043145). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prioritypharmaceuticals.com.
Company details
CIN U24232RJ2011PTC035282
Registration Number 035282
Incorporation Date 23 May 2011
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-RJ-17-0043145
Recognitions & Rankings of Priority Pharmaceuticals
Contact details
Priority Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its website is prioritypharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 194 2nd Floor Near Moti Park Bapu Nagar, Jaipur, Rajasthan, India – 302015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Priority Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Priority Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Priority Pharmaceuticals operates one associated brand: Priority Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of tablets, capsules, drops, and injectables | prioritypharmaceuticals.com |
Business activity
The main business activity of Priority Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Priority Pharmaceuticals Private Limited, buy the company report.
Financials of Priority Pharmaceuticals Private Limited
FY 2025 filings availablePriority Pharmaceuticals Private Limited reported revenue of ₹7.12 Cr (up 174% YoY) for FY 2025.
Revenue · FY 2025
₹7.12 Cr ▲ 174%
Net profit · FY 2025
₹15.66 Lakh margin 2.2%
EBITDA · FY 2025
₹61.8 Lakh margin 8.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 174%
3 years · compounded
▲ 63%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▲ 92%
3 years · compounded
▲ 56%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 174% growth in the latest year. EBITDA rose 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.8 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.66 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.7% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Priority Pharmaceuticals Private Limited, buy the company report.
Board of directors of Priority Pharmaceuticals Private Limited
Priority Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sonakshi Jain Also directs: Siddhika Tradex LLP, Perficient Strategies Private Limited | Director | 23 May 2011 | 15 Years 5 Months | Current |
| Sanjay Kumar Patni | Director | 23 May 2011 | 15 Years 5 Months | Current |
| Manju Jain | Director | 23 May 2011 | 15 Years 5 Months | Current |
| Abhishek Jain | Director | 23 May 2011 | 15 Years 5 Months | Current |
Peer comparison
Priority Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Solace Biotech Limited | ₹7.14 Cr (FY 2024) | -8.0% | Saha, Haryana, India | |||
| Worth Medicines India Private Limited | ₹7.12 Cr (FY 2024) | 2.0% | Himachal Pradesh, India | |||
| Priority Pharmaceuticals Private Limitedthis company | ₹7.12 Cr (FY 2025) | ₹15.66 Lakh | 2.2% | 174.0% | Jaipur, Rajasthan, India | |
| Gladje Pharmaceuticals Private Limited | ₹7.09 Cr (FY 2025) | 94.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Priority Pharmaceuticals Private Limited, buy the company report.
Auditor
Priority Pharmaceuticals Private Limited is audited by A. K. Khandelwal & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A. K. Khandelwal & Co. | FY 2022 | 006122C |
Shareholding
The shareholding of Priority Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Priority Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹58.24 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2023 | 100674085 | Hdfc Bank Limited | ₹10.48 Lakh | Open | |
| 07 Dec 2015 | 10609833 | The South Indian Bank Limited | ₹47.76 Lakh | Open |
To see the full charge records of Priority Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Priority Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Priority Pharmaceuticals Private Limited has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Decibel Biotech | |||
| an individual supplier |
To see the full MSME payment records of Priority Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Priority Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCP0181N1Z4 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Priority Pharmaceuticals Private Limited, buy the company report.
Recent activity
Priority Pharmaceuticals Private Limited has 4 board changes on record since 2011: 4 appointments. The latest: Abhishek Jain was appointed as Director on 23 May 2011.
AGM
Priority Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Priority Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.48 Lakh with Charge ID 100674085 was registered on 24 Jan 2023.
Charges
A charge with The South Indian Bank Limited of Rs. 47.76 Lakh registered on 07 Dec 2015 with Charge ID 10609833 was modified on 08 Jun 2020.
Charges
A charge with The South Indian Bank Limited amounted to Rs. 47.76 Lakh with Charge ID 10609833 was registered on 07 Dec 2015.
Appointed
Abhishek Jain was appointed as Director.
Appointed
Manju Jain was appointed as Director.
Appointed
Sanjay Kumar Patni was appointed as Director.
Appointed
Sonakshi Jain was appointed as Director.
Incorporation
23 May 2011
Priority Pharmaceuticals Private Limited was registered on 23 May 2011 with Roc Jaipur & aged 15 years 5 months as per MCA records.
Frequently asked questions
Priority Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 May 2011 (15+ years old) and is registered under CIN U24232RJ2011PTC035282.
Priority Pharmaceuticals has 4 current directors:
- Sonakshi Jain - Director
- Sanjay Kumar Patni - Director
- Manju Jain - Director
- Abhishek Jain - Director
The latest financial statements of Priority Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Priority Pharmaceuticals is 08AAGCP0181N1Z4, registered in Rajasthan.
The CIN (Corporate Identification Number) of Priority Pharmaceuticals is U24232RJ2011PTC035282. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Priority Pharmaceuticals was incorporated on 23 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Priority Pharmaceuticals by revenue are Solace Biotech Limited, Worth Medicines India Private Limited, Gladje Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Abhishek Jain was appointed as Director on 23 May 2011. Manju Jain was appointed as Director on 23 May 2011. Sanjay Kumar Patni was appointed as Director on 23 May 2011. Priority Pharmaceuticals has 4 board changes on record in total.
Yes, Priority Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0043145).
Priority Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Jan 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 10 Jul 2019.
Priority Pharmaceuticals can be reached through the website prioritypharmaceuticals.com. Its registered office is in Jaipur, Rajasthan, India.
The registered office of Priority Pharmaceuticals is at D – 194 2nd Floor Near Moti Park Bapu Nagar, Jaipur, Rajasthan, India – 302015.